vivani.com (VANI) - מזומנים למניה אחת

Vivani Medical, Inc. (VANI) develops implantable systems that provide multi-year therapy without injections. The cash per share history helps assess liquidity for development, with 0.16 representing the latest metric reading. The company replaces daily GLP-1 injections with semi-annual devices for diabetics. Technological superiority in ultra-long-term treatment offsets the high binary risks associated with a narrow development portfolio.
פילוחי מדדים מקיפים ואנליטיקה עבור Vivani Medical Inc (VANI)

Cash per share measures the portion of net cash reserves attributable to a single security. This metric determines a business's financial autonomy and its ability to withstand market volatility. By analyzing the calculated cash per share, an investor assesses real liquidity excluding debt obligations. For Vivani Medical (VANI), this reserve is critically important when undergoing rigorous FDA inspections. Capital ensures the development of proprietary implants, creating an insurmountable barrier for competitors.